Allworth Financial’s SELLAS Life Sciences SLS Stock Holding History

Allworth Financial’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.97K	Buy	472 +446	+1,715%	+$3.08K	﹤0.01%	3944
2026 Q1	$110	Buy	+26	New	+$116	﹤0.01%	4999
2024 Q3	–	Sell	-150	Closed	-$167	–	3823
2024 Q2	$167	Hold	150	–	–	﹤0.01%	3569
2024 Q1	$152	Hold	150	–	–	﹤0.01%	3474
2023 Q4	$159	Hold	150	–	–	﹤0.01%	3313
2023 Q3	$246	Hold	150	–	–	﹤0.01%	3204
2023 Q2	$236	Hold	150	–	–	﹤0.01%	3067
2023 Q1	$215	Hold	150	–	–	﹤0.01%	2998
2022 Q4	$354	Hold	150	–	–	﹤0.01%	2708
2022 Q3	$0	Hold	150	–	–	﹤0.01%	3074
2022 Q2	$0	Hold	150	–	–	﹤0.01%	2770
2022 Q1	$1K	Hold	150	–	–	﹤0.01%	2018
2021 Q4	$1K	Hold	150	–	–	﹤0.01%	1858
2021 Q3	$1K	Hold	150	–	–	﹤0.01%	1798
2021 Q2	$2K	Hold	150	–	–	﹤0.01%	1403
2021 Q1	$1K	Buy	+150	New	+$1.23K	﹤0.01%	1426

Other funds holding SLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Allworth Financial's SLS Position: Q2 2026 in Review

Allworth Financial increased its SELLAS Life Sciences (SLS) stake by 1,715% in Q2 2026, buying an estimated $3.08K and bringing the position to 472 shares worth $6.97K. The position accounts for ﹤0.01% of the portfolio, ranked #3944.

Allworth Financial first reported a position in SLS in Q1 2021 and has held it in 16 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

Allworth Financial held 472 shares of SELLAS Life Sciences worth $6.97K as of Q2 2026.
Allworth Financial bought 446 SELLAS Life Sciences shares in Q2 2026, an estimated $3.08K.
SELLAS Life Sciences made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3944 holding.
Allworth Financial first reported a position in SELLAS Life Sciences in Q1 2021 and has held it in 16 quarters since.
192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.